Gene Therapy Company AavantiBio Launches with $107 Million Series A Financing from Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/34mJQJn
via IFTTT